黄素可以减少长期COVID患者的疲劳,研究发现 Fluvoxamine reduces fatigue in long COVID patients, study finds

2026年3月发表的一项临床试验发现抗抑郁药黄素显著减少了长期COVID患者的疲劳. A clinical trial published in March 2026 found that the antidepressant fluvoxamine significantly reduced fatigue in adults with long COVID. 这项研究表明,黄素比安慰剂更有效,而甲型胺则没有益处. The study showed fluvoxamine was more effective than a placebo, while metformin showed no benefit. 对于数百万受这种疾病影响的人来说, 这是一个有希望的可获得治疗方案. Researchers say this offers a promising, accessible treatment option for the millions affected by the condition.